The nurse is analyzing complete blood count (CBC) results to identify findings consistent with acute leukemia diagnosis. Which laboratory finding would be most indicative of acute leukemia?

Blast cells >20% in peripheral blood is the diagnostic hallmark of acute leukemia per WHO criteria. Other CBC findings (anemia, normal platelets, mild leukocytosis) are nonspecific and not diagnostic.

Understanding the Question

This question asks you to identify the laboratory finding most indicative of acute leukemia. While a complete blood count (CBC) provides valuable clues, the definitive diagnosis of acute leukemia hinges on identifying the malignant cells directly. The key is to distinguish between supportive but nonspecific CBC abnormalities and a finding that is pathognomonic for the disease.

Analyzing the Options

To determine the most indicative finding, it is essential to understand what each CBC component represents in the context of acute leukemia.

* Option 1: Hemoglobin level of 10.5 g/dL
This represents mild anemia. In acute leukemia, anemia is a common finding due to the crowding out of normal hematopoietic cells in the bone marrow by rapidly proliferating leukemic blasts . However, anemia is a nonspecific finding that can result from countless other conditions, such as iron deficiency, chronic disease, or blood loss. Therefore, while consistent with acute leukemia, it is not the most indicative finding.

* Option 2: Platelet count of 150,000/mm³
This value falls within the typical normal reference range (approximately 150,000–400,000/mm³). A normal platelet count does not support a diagnosis of acute leukemia, where thrombocytopenia is a hallmark finding due to the same bone marrow replacement process that causes anemia . This finding makes acute leukemia less likely.

* Option 3: White blood cell count of 12,000/mm³
This represents a mild leukocytosis. While the white blood cell (WBC) count can be markedly elevated in some cases of acute leukemia, it can also be normal or even low. More importantly, the WBC count is a quantitative measure and does not provide qualitative information about the type of cells present. A mild elevation like this is a nonspecific finding commonly seen in infections, inflammation, or stress responses and is not specific to a malignant process.

* Option 4: Presence of blast cells in peripheral blood
This is the hallmark of acute leukemia. The fundamental pathophysiology of acute leukemia is the uncontrolled proliferation of immature hematopoietic precursor cells, known as blasts, in the bone marrow. These malignant blasts spill over into the peripheral blood, where they are not normally found in significant numbers. The identification and quantification of blasts on a peripheral blood smear is a central, defining diagnostic criterion for acute leukemias [2, 3]. Advanced diagnostic methods, such as flow cytometry-based peripheral blood leukocyte classification, are used to screen for and confirm the presence of these abnormal blast populations with high precision . The presence of leukemic blasts in tissues, such as the skin (leukemia cutis), can even be the initial presenting sign of systemic disease, as documented in a case of newly diagnosed acute myeloid leukemia . This finding is a direct visualization of the malignant clone and is therefore the most indicative laboratory finding.

The Correct Answer and Clinical Rationale

The most indicative finding is the presence of blast cells in peripheral blood.

The diagnosis of acute leukemia is not based on cytopenias or total cell counts alone but on the direct morphological and immunophenotypic identification of the neoplastic cells. The detection of blasts in the peripheral blood is a direct consequence of the disease's pathophysiology. As leukemic blasts fill the bone marrow, they disrupt the normal architecture and are released into the circulation. Modern diagnostic workflows emphasize the critical role of peripheral blood analysis. While manual microscopy remains central, next-generation digital morphology and artificial intelligence are being developed to automate and improve the accuracy of blast preclassification and detection on peripheral blood smears [2, 3]. Furthermore, flow cytometry on peripheral blood is a powerful tool for classifying these leukocytes, providing a rapid and accurate method for acute leukemia screening and distinguishing it from benign reactive conditions . The finding of blasts in the peripheral blood is a direct, qualitative marker of the malignant process, making it far more specific than any single numeric abnormality on a CBC.